Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global neurorehabilitation devices market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 12.26% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Neurorehabilitation devices refer to the equipment used for examination of the brain and central nervous system (CNS). Some of the commonly used devices include neurorobotic systems, non-invasive brain stimulators, neuroprosthetics, brain-computer interfaces and wearable devices. These devices assist in the diagnosis and treatment of a disease, disorder or injury in the nervous system of the patient. They facilitate in re-learning motor skills and optimal recovery from neurological disorders, such as Parkinson’s disease, and cardiovascular stroke. As a result, neurorehabilitation devices find extensive applications across various clinics, cognitive care and research institutes and healthcare centers.
Neurorehabilitation Devices Market Trends:
The increasing prevalence of neurological diseases, such as multiple sclerosis, Parkinson’s disease and cerebral palsy, is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Neurorehabilitation devices aid in deploying diversified electric signals to multiple fibers of the spinal cord for the recovery of limb movements. Additionally, various technological advancements, such as the gamification of rehabilitation activities through virtual reality (VR), robotics and artificial intelligence (AI), that aid in promoting recovery are acting as other growth-inducing factors. In line with this, the utilization of novel multi-electrode stimulation for the treatment of spinal cord injuries is also contributing to the market growth. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurorehabilitation devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end user.
Breakup by Product Type:
Neurorobotic Devices
Wearable Devices
Non-Invasive Stimulators
Brain-Computer Interface
Breakup by Application:
Stroke
Multiple Sclerosis
Parkinson's Disease
Cerebral Palsy
Others
Breakup by End User:
Hospitals and Clinics
Cognitive Care Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.
Key Questions Answered in This Report:
How has the global neurorehabilitation devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurorehabilitation devices market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurorehabilitation devices market and who are the key players?
What is the degree of competition in the industry?
Neurorehabilitation devices refer to the equipment used for examination of the brain and central nervous system (CNS). Some of the commonly used devices include neurorobotic systems, non-invasive brain stimulators, neuroprosthetics, brain-computer interfaces and wearable devices. These devices assist in the diagnosis and treatment of a disease, disorder or injury in the nervous system of the patient. They facilitate in re-learning motor skills and optimal recovery from neurological disorders, such as Parkinson’s disease, and cardiovascular stroke. As a result, neurorehabilitation devices find extensive applications across various clinics, cognitive care and research institutes and healthcare centers.
Neurorehabilitation Devices Market Trends:
The increasing prevalence of neurological diseases, such as multiple sclerosis, Parkinson’s disease and cerebral palsy, is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Neurorehabilitation devices aid in deploying diversified electric signals to multiple fibers of the spinal cord for the recovery of limb movements. Additionally, various technological advancements, such as the gamification of rehabilitation activities through virtual reality (VR), robotics and artificial intelligence (AI), that aid in promoting recovery are acting as other growth-inducing factors. In line with this, the utilization of novel multi-electrode stimulation for the treatment of spinal cord injuries is also contributing to the market growth. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurorehabilitation devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end user.
Breakup by Product Type:
Neurorobotic Devices
Wearable Devices
Non-Invasive Stimulators
Brain-Computer Interface
Breakup by Application:
Stroke
Multiple Sclerosis
Parkinson's Disease
Cerebral Palsy
Others
Breakup by End User:
Hospitals and Clinics
Cognitive Care Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.
Key Questions Answered in This Report:
How has the global neurorehabilitation devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurorehabilitation devices market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurorehabilitation devices market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEUROREHABILITATION DEVICES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Neurorobotic Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Wearable Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Non-Invasive Stimulators
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain-Computer Interface
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Multiple Sclerosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Parkinson's Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cerebral Palsy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cognitive Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biometrics Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bioness Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bionik Laboratories Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 BioXtreme Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Boston Scientific Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Ectron Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Ekso Bionics
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Hocoma AG (DIH International Limited)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Kinestica
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Kinova Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Medtronic plc
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Saebo Inc
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Tyromotion GmbH
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEUROREHABILITATION DEVICES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Neurorobotic Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Wearable Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Non-Invasive Stimulators
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain-Computer Interface
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Multiple Sclerosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Parkinson's Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cerebral Palsy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cognitive Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biometrics Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bioness Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bionik Laboratories Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 BioXtreme Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Boston Scientific Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Ectron Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Ekso Bionics
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Hocoma AG (DIH International Limited)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Kinestica
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Kinova Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Medtronic plc
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Saebo Inc
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Tyromotion GmbH
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
LIST OF TABLES
Table 1: Global: Neurorehabilitation Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Neurorehabilitation Devices Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Neurorehabilitation Devices Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Neurorehabilitation Devices Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Neurorehabilitation Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Neurorehabilitation Devices Market: Competitive Structure
Table 7: Global: Neurorehabilitation Devices Market: Key Players
Table 1: Global: Neurorehabilitation Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Neurorehabilitation Devices Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Neurorehabilitation Devices Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Neurorehabilitation Devices Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Neurorehabilitation Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Neurorehabilitation Devices Market: Competitive Structure
Table 7: Global: Neurorehabilitation Devices Market: Key Players
LIST OF FIGURES
Figure 1: Global: Neurorehabilitation Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurorehabilitation Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Neurorehabilitation Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Neurorehabilitation Devices Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Neurorehabilitation Devices Market: Breakup by Application (in %), 2021
Figure 6: Global: Neurorehabilitation Devices Market: Breakup by End User (in %), 2021
Figure 7: Global: Neurorehabilitation Devices Market: Breakup by Region (in %), 2021
Figure 8: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Neurorehabilitation Devices (Wearable Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Neurorehabilitation Devices (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Neurorehabilitation Devices (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Neurorehabilitation Devices (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Neurorehabilitation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Neurorehabilitation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Neurorehabilitation Devices (Cerebral Palsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Neurorehabilitation Devices (Cerebral Palsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Neurorehabilitation Devices (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Neurorehabilitation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Neurorehabilitation Devices (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Neurorehabilitation Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Neurorehabilitation Devices Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Neurorehabilitation Devices Industry: SWOT Analysis
Figure 82: Global: Neurorehabilitation Devices Industry: Value Chain Analysis
Figure 83: Global: Neurorehabilitation Devices Industry: Porter's Five Forces Analysis
Figure 1: Global: Neurorehabilitation Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurorehabilitation Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Neurorehabilitation Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Neurorehabilitation Devices Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Neurorehabilitation Devices Market: Breakup by Application (in %), 2021
Figure 6: Global: Neurorehabilitation Devices Market: Breakup by End User (in %), 2021
Figure 7: Global: Neurorehabilitation Devices Market: Breakup by Region (in %), 2021
Figure 8: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Neurorehabilitation Devices (Wearable Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Neurorehabilitation Devices (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Neurorehabilitation Devices (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Neurorehabilitation Devices (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Neurorehabilitation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Neurorehabilitation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Neurorehabilitation Devices (Cerebral Palsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Neurorehabilitation Devices (Cerebral Palsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Neurorehabilitation Devices (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Neurorehabilitation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Neurorehabilitation Devices (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Neurorehabilitation Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Neurorehabilitation Devices Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Neurorehabilitation Devices Industry: SWOT Analysis
Figure 82: Global: Neurorehabilitation Devices Industry: Value Chain Analysis
Figure 83: Global: Neurorehabilitation Devices Industry: Porter's Five Forces Analysis
